Table S4 from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations
收藏NIAID Data Ecosystem2026-04-29 收录
数据链接：
官方服务：
资源简介：
Table S4. Inactivating mutations in TSC1/TSC2 and activating mutation in MTOR identified in 30 patients in the clinical trial - clonality and biallelic TSC1/TSC2 inactivation status.
创建时间：
2021-07-15
